Comparative effectiveness of GLP-1 receptor agonists vs DPP-4 inhibitors in patients with type 2 diabetes and moderate/severe chronic kidney disease

Document Type

Presentation

Publication Date

1-1-2023

Keywords

washington; spokane; pmrc

Abstract

EASD 2023

Clinical Institute

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Nephrology

Comments

Tuttle KR, Fioretto P, Clark A, Boeck Jenson A, Belmar Nazal N, Rossing P

This document is currently not available here.


Share

COinS